FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileWalgreens Boots Alliance, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WBA
Walgreens Boots Alliance, Inc. Stock AnalysisComprehensive stock analysis for Walgreens Boots Alliance, Inc. (WBA) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWBA
WBA
Walgreens Boots Alliance, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
WBA
  1. Home
  2. Stocks
  3. Walgreens Boots Alliance, Inc.
WB

Walgreens Boots Alliance, Inc.

🇺🇸WBA•NASDAQ
WB

Walgreens Boots Alliance, Inc.

🇺🇸WBA•NASDAQ
Market cap
$10.37B
Sentiment

Your view on WBA

Mkt Cap
$10.37B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Walgreens Boots Alliance, Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Timothy C. Wentworth
Headquarters
US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Timothy C. Wentworth
Headquarters
US
Description

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International.

The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services.

As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies.

The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application.

It also engages in pharmaceutical wholesaling and distribution business in Germany.

As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis.

Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Walgreens Boots Alliance, Inc. from FRC's valuation model, read against the market price. WBA last traded at $11.98; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Walgreens Boots Alliance, Inc.. Starting points for Walgreens Boots Alliance, Inc.: EPS -$10.01, beta 0.77 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. paid $1.00 per share over the last year — a 8.3% yield at the current $11.98 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Walgreens Boots Alliance, Inc.. Trailing twelve-month EPS for Walgreens Boots Alliance, Inc. stands at -$10.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$23.57

average of analysts' targets

 

$23.57

Low $9.00

Median $13.00

High $57.00

 

Analyst Ratings

Hold31 ratings
  • Strong Buy0
  • Buy5
  • Hold17
  • Sell9
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrAug 2025Next QtrNov 2025Current YearFY Aug 2025Next YearFY Aug 2026
Avg. estimate$0.24$0.43$1.77$1.57
Low estimate$0.19$0.43$1.68$1.13
High estimate$0.30$0.43$1.86$1.73
No. of analysts4165
Year-ago EPS$0.39$0.51-$10.01—
Growth-39.1%-16.2%+117.7%—

Revenue Estimate

RevenueCurrent QtrAug 2025Next QtrNov 2025Current YearFY Aug 2025Next YearFY Aug 2026
Avg. estimate$37.41B$39.26B$154.47B$155.99B
Low estimate$35.98B$36.88B$151.79B$146.86B
High estimate$38.81B$41.63B$157.94B$162.14B
No. of analysts4277
Year-ago revenue$37.55B$39.46B$147.66B—
Growth-0.4%-0.5%+4.6%—
Recent analyst actions15 rating and price-target changes, latest Feb 28, 2025 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold WBA20 companies
Compare WBA with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ABBVAbbVie Inc.Drug Manufacturers - General$520.9B
  • BIMIBIMI International Medical Inc.Medical - Distribution$1,156
  • CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
  • HITIHigh Tide Inc.Medical - Pharmaceuticals$211M
  • KHCThe Kraft Heinz CompanyPackaged Foods$29.7B
  • MMM3M CompanyConglomerates$93.9B
  • PETSPetMed Express, Inc.Specialty Retail$20M
  • RDGTRidgetech Inc.Medical - Distribution$4M

More Medical - Pharmaceuticals companies

  • TRGMTargeted Medical Pharma, Inc.OTC$3,019
  • TSUSFTsuruha Holdings Inc.OTC$4.2B
  • UPPRUpper Street Marketing Inc.OTC$7,995
  • VIAPVIA Pharmaceuticals, Inc.OTC$10,279
  • WPHMWinston Pharmaceuticals, Inc.OTC$23,223
  • WUHNWuhan General Group (China), Inc.OTC$22,060
  • NEUNNeurogenesis, Inc.OTC$8,226
  • NEXINexImmune, Inc.OTC$279
  • NSRXNasus Pharma Ltd.AMEX$23M
  • NUNZNunzia Pharmaceutical CompanyOTC$43,451
  • OMHEOmni Health, Inc.OTC$29,291
  • ORXOFOrexo AB (publ)OTC$111M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Walgreens Boots Alliance, Inc., and how their positions are changing. At a $10.37B market value, institutional positions materially move Walgreens Boots Alliance, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Walgreens Boots Alliance, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Walgreens Boots Alliance, Inc.. Walgreens Boots Alliance, Inc. is a $10.37B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Walgreens Boots Alliance, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Walgreens Boots Alliance, Inc.. Coverage tracks Walgreens Boots Alliance, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Walgreens Boots Alliance, Inc.

WBA Analysis
Weak
Past2
Growth3
Health2
Profit1
Value1

News

Latest Market News